RACHEL VANTRIES: Open Payments
NPI 1700537461 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 56 payments from 13 companies in 2025. Trend: 2023 $267 · 2024 $1,571 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $367 |
| ABBVIE INC. | 9 | $143 |
| Axsome Therapeutics, Inc. | 6 | $140 |
| Tris Pharma Inc | 5 | $88 |
| Corium, LLC | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| Alkermes, Inc. | 3 | $60 |
| Almatica Pharma LLC | 3 | $53 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $46 |
Products named: HETLIOZ, VRAYLAR, FANAPT, Auvelity, Dyanavel XR, Azstarys, CAPLYTA, Jornay PM.
Industry payments across IN — which companies pay providers there.
